Skip to content
CancerIndex

Ranking · Unmet Need

Trial Gap Index

Burden percentile minus active-trial percentile within the same scope. Positive values flag cancers with high mortality burden but comparatively few active trials. A quantitative signal, not an accusation (CLAUDE.md §324). Caveat (Phase 1): trial counts aggregate a cancer and its NCIt descendants only; registrations phrased at a broader level (e.g. "colorectal cancer" for colon and rectal cancer) are attributed to the broader entity, which can overstate the gap of narrower top-level sites.

Computedci-trial-gap-v1unit: percentile pointshigher = worseAll metrics

Top 15 by Trial Gap IndexMalignant Colon Neoplasm+55.6Malignant Vulvar Neoplasm+22.2Cutaneous Melanoma+18.5Malignant Ovarian Neoplasm+14.8Malignant Bladder Neoplasm+11.2Malignant Vaginal Neoplasm+11.1Malignant Laryngeal Neoplasm+11.1Malignant Pancreatic Neoplasm+7.4Malignant Kidney Neoplasm+7.4Malignant Rectal Neoplasm+3.8Malignant Thyroid Gland Neopl…+3.7Malignant Breast Neoplasm0Malignant Lung Neoplasm0Malignant Anal Neoplasm-3.7Malignant Salivary Gland Neop…-3.7
RankΔCancerTrial Gap Index (percentile points)PercentileConfidenceSourcesWhy #n?
1=Malignant Colon Neoplasm+55.6100Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
21863
formula
percentile(mortality_count) − percentile(active_trials)
activity
225
burdenPercentile
92.6
activityPercentile
37

ranking row 2597068

2=Malignant Vulvar Neoplasm+22.296.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
921
formula
percentile(mortality_count) − percentile(active_trials)
activity
54
burdenPercentile
29.6
activityPercentile
7.4

ranking row 2597069

3=Cutaneous Melanoma+18.592.6Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
2951
formula
percentile(mortality_count) − percentile(active_trials)
activity
78
burdenPercentile
40.7
activityPercentile
22.2

ranking row 2597070

4=Malignant Ovarian Neoplasm+14.888.9Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
14362
formula
percentile(mortality_count) − percentile(active_trials)
activity
684
burdenPercentile
85.2
activityPercentile
70.4

ranking row 2597071

5=Malignant Bladder Neoplasm+11.285.2Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
4245
formula
percentile(mortality_count) − percentile(active_trials)
activity
346
burdenPercentile
55.6
activityPercentile
44.4

ranking row 2597072

6=Malignant Vaginal Neoplasm+11.181.5Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
417
formula
percentile(mortality_count) − percentile(active_trials)
activity
31
burdenPercentile
11.1
activityPercentile
0

ranking row 2597073

7=Malignant Laryngeal Neoplasm+11.177.8Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
811
formula
percentile(mortality_count) − percentile(active_trials)
activity
66
burdenPercentile
25.9
activityPercentile
14.8

ranking row 2597074

8=Malignant Pancreatic Neoplasm+7.474.1Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
17719
formula
percentile(mortality_count) − percentile(active_trials)
activity
904
burdenPercentile
88.9
activityPercentile
81.5

ranking row 2597075

9=Malignant Kidney Neoplasm+7.470.4Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
4689
formula
percentile(mortality_count) − percentile(active_trials)
activity
453
burdenPercentile
63
activityPercentile
55.6

ranking row 2597076

10=Malignant Rectal Neoplasm+3.866.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
4061
formula
percentile(mortality_count) − percentile(active_trials)
activity
386
burdenPercentile
51.9
activityPercentile
48.1

ranking row 2597077

11=Malignant Thyroid Gland Neoplasm+3.763Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
962
formula
percentile(mortality_count) − percentile(active_trials)
activity
176
burdenPercentile
33.3
activityPercentile
29.6

ranking row 2597078

12=Malignant Breast Neoplasm059.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
40589
formula
percentile(mortality_count) − percentile(active_trials)
activity
2627
burdenPercentile
96.3
activityPercentile
96.3

ranking row 2597079

12=Malignant Lung Neoplasm059.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
70051
formula
percentile(mortality_count) − percentile(active_trials)
activity
2644
burdenPercentile
100
activityPercentile
100

ranking row 2597080

14=Malignant Anal Neoplasm-3.751.9Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
444
formula
percentile(mortality_count) − percentile(active_trials)
activity
68
burdenPercentile
14.8
activityPercentile
18.5

ranking row 2597082

14=Malignant Salivary Gland Neoplasm-3.751.9Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
244
formula
percentile(mortality_count) − percentile(active_trials)
activity
63
burdenPercentile
7.4
activityPercentile
11.1

ranking row 2597081

16=Malignant Hypopharyngeal Neoplasm-3.744.4Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
71
formula
percentile(mortality_count) − percentile(active_trials)
activity
53
burdenPercentile
0
activityPercentile
3.7

ranking row 2597083

17=Malignant Central Nervous System Neoplasm-3.740.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
6038
formula
percentile(mortality_count) − percentile(active_trials)
activity
823
burdenPercentile
74.1
activityPercentile
77.8

ranking row 2597084

18=Multiple Myeloma-7.437Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
4787
formula
percentile(mortality_count) − percentile(active_trials)
activity
814
burdenPercentile
66.7
activityPercentile
74.1

ranking row 2597085

19=Malignant Mesothelioma-7.433.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
528
formula
percentile(mortality_count) − percentile(active_trials)
activity
96
burdenPercentile
18.5
activityPercentile
25.9

ranking row 2597086

20=Leukemia-7.429.6Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
9673
formula
percentile(mortality_count) − percentile(active_trials)
activity
1769
burdenPercentile
81.5
activityPercentile
88.9

ranking row 2597087

20=Malignant Gastric Neoplasm-7.429.6Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
4617
formula
percentile(mortality_count) − percentile(active_trials)
activity
652
burdenPercentile
59.3
activityPercentile
66.7

ranking row 2597088

22=Malignant Uterine Corpus Neoplasm-7.522.2Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
3436
formula
percentile(mortality_count) − percentile(active_trials)
activity
411
burdenPercentile
44.4
activityPercentile
51.9

ranking row 2597089

23=Hodgkin Lymphoma-11.118.5Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
532
formula
percentile(mortality_count) − percentile(active_trials)
activity
179
burdenPercentile
22.2
activityPercentile
33.3

ranking row 2597090

24=Malignant Cervical Neoplasm-11.214.8Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
4008
formula
percentile(mortality_count) − percentile(active_trials)
activity
505
burdenPercentile
48.1
activityPercentile
59.3

ranking row 2597091

25=Malignant Liver Neoplasm-14.811.1Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
5911
formula
percentile(mortality_count) − percentile(active_trials)
activity
906
burdenPercentile
70.4
activityPercentile
85.2

ranking row 2597093

25=Non-Hodgkin Lymphoma-14.811.1Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
9365
formula
percentile(mortality_count) − percentile(active_trials)
activity
2168
burdenPercentile
77.8
activityPercentile
92.6

ranking row 2597092

27=Malignant Esophageal Neoplasm-263.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
2867
formula
percentile(mortality_count) − percentile(active_trials)
activity
518
burdenPercentile
37
activityPercentile
63

ranking row 2597094

28=Malignant Nasopharyngeal Neoplasm-370Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
209
formula
percentile(mortality_count) − percentile(active_trials)
activity
261
burdenPercentile
3.7
activityPercentile
40.7

ranking row 2597095

Data updated 16 hours agoSource updated unknown28 eligible entities · inputs hash 7e6116a35bed0ffade88f249